https://www.selleckchem.com/pr....oducts/SB-743921.htm
high-dose cefotaxime monotherapy for treating pneumococcal meningitis with susceptible strains to cefotaxime. Despite the use of aggressive multimodality treatment, most anaplastic thyroid carcinoma (ATC) patients die within a year of diagnosis. Although the combination of BRAF and MEK inhibitors has recently been approved for use in BRAF-mutated ATC, they remain effective in a minority of patients who are likely to develop drug resistance. There remains a critical clinical need for effective systemic agents for ATC with a reasonable
Like
Comment
Share
